Tuberculosis and human immunodeficiency virus infection in West Burkina Faso: Clinical presentation and clinical evolution

International Journal of Tuberculosis and Lung Disease

Volumn 1, Issue 1, 1997, Pages 68-74

  Malkin, J E ^a,d   Prazuck, T ^a   Simonnet, F ^b   Yameogo, M ^a   Rochereau, A ^c   Ayeroue, J ^b   Masson, D ^c   Lafaix, C ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b Centre Anti tuberculeux   (Burkina Faso)

^c CENTRE MURAZ   (Burkina Faso)

^d Centre Hospitalier Intercommunal de Villeneuve Saint Georges   (France)

Author keywords

Cohort study; HIV infection; Tuberculosis; West Africa

Indexed keywords

ADULT; AFRICA; AGE DISTRIBUTION; AGED; AIDS RELATED COMPLEX; ANALYSIS OF VARIANCE; ARTICLE; COHORT ANALYSIS; DEVELOPING COUNTRY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; MALE; MIDDLE AGED; RISK FACTOR; SEX RATIO; STATISTICAL MODEL; SURVIVAL RATE; TUBERCULOSIS;

ADULT; AFRICA; AGE DISTRIBUTION; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANALYSIS OF VARIANCE; COHORT STUDIES; DEVELOPING COUNTRIES; FEMALE; HIV SEROPREVALENCE; HIV-1; HIV-2; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; TUBERCULOSIS;

EID: 0031061446     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Piot P, Quinn T C, Taelman H. Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet 1984; 2: 65-69.
2. Raviglione M C, Narain J P, Kochi A. HIV-associated tuberculosis in developing countries: clinical features, diagnosis and treatment. Bull World Health Organ 1992; 70: 515-526.
3. Murray C J L, Stybio K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990; 65: 6-24.
4. De Cock K, Gnaore E, Abjorbolo G, Braun M M, Lafontaine M F, Yesso G. Risk of tuberculosis m patients with HIVI and HIVII infections in Abidjan, Ivory Coast. Brit Med J 1991; 302: 496-499.
5. Long R, Scalcini M, Manfreda J, Carre G, Philippe E, Hershfield E. Impact of human immunodeficiency virus type 1 on tuberculosis in rural Haiti. Am Rev Respir Dis 1991; 143: 69-73.
6. Mann J, Snider D E, Francis H, Quinn T, Colebunders R, Plot P. Association between HTLV-III/LAV infection and tuberculosis in Zaire. JAMA 1986; 256: 346.
7. Kelly P, Burnham G, Radford C. HIV seropositivity and tuberculosis in a rural Malawi population. Trans Soc Trop Med Hyg 1990; 8: 725-727.
8. Colebunders R, Ryder R, Neilambi N, Dikilu K, Willame J C, Kaboyo M. HIV infection in patients with tuberculosis in Kinshasa, Zaire. Am Rev Respir Dis 1989; 139: 1082-1085.
9. De Cock K M, Soro B, Coulibaly I M, Lucas S B. Tuberculose and HIV infection in sub-Saharan Africa. JAMA 1992; 12: 1581-1587.
10. Kassim S, Sassan-Morokro M, Ackah A, et al. Two-year follow up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa. AIDS 1995; 9: 1185-1191.
11. Prazuck T, Yameogo J M V, Heylinck B, et al. Mother to child transmission of human immunodeficiency viruses type A and type 2 and dual infection: a cohort study in Banfora, Burkina Faso. Pediatr Infect Dis J 1995; 14: 940-947.
12. Centers for Disease Control, Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36 (suppl: 1-15).
13. Elliot A M, Luo N, Tembo G, Halwimdi B, Steenbergen G, Machiz L. Impact of tuberculosis in Zambia: a cross-sectional study. Brit Med J 1990; 301: 412-415.
14. Widy-Wirski R, Berkley S, Downing R. Evaluation of the WHO clinical case definition for AIDS in Uganda. JAMA 1988; 260: 3286-3289.
15. Soro BN, Gershy-Damet G M, Coulibaly A. Seroprevalence of HIV infection in the general population of the Ivory Coast, West Africa, J Acquir Immune Defic Syndr 1990; 3: 283-289.
16. Romieu I, Marlink R, Kanki P, M'boup S, Essex M. HIV2 link to AIDS in West Africa. J Acquir Immune Defic Syndr 1990; 3: 220-230.
17. Pitchenik A E, Cole C C, Russell B W, et al. Tuberculosis, atypical mycobactenosis, and the acquired immunodeficiency syndrome among Haitian and non Haitian patients in south Florida. Ann Intern Med 1984; 101: 641-645.
18. Gilks C F, Brindle R J, Otieno L S. Extrapulmonary and disseminated tuberculosis in HIV-1 seropositive patients presenting to the acute medical services in Nairobi. AIDS 1988; 4: 981-985.
19. Barnes P F, Bloch A B, Davidson P T. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 324: 1644-1650.
20. Handwerger S, Mildvan D, Senie R. Tuberculosis and the acquired immunodeficiency syndrome at a New York City hospital: 1978-1985. Chesr 1987; 91: 176-180.
21. Soriano E, Mallolas J, Gatell J M. Characteristics of tuberculosis in HIV infected patients: a case control study. AIDS 1988; 2: 429-432.
22. Gnaore E, Sassan-Moroko M, Kassim S, et al. A comparison of clinical features in tuberculosis associated with infection with human immunodeficiency viruses 1 and 2. Trans Roy Soc Trop Med Hyg 1993; 87: 57-59.
23. De Cock K M, Adjorlodo G, Ekpini E, Sibally T, Kouadio J, Maran M. Epidemiology and transmission of HIV-2: why there is no HIV-2 pandemic. JAMA 1993; 17: 2083-2086.
24. Simon F, Matheron S, Tamalet C, Loussert-Ajaki I, Bartczak S, Pepin J M. Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993; 7; 11: 1411-1417.
25. Pernens J, Colebunders R, Karahunga C, Willame J C, Jeugmans J, Kaboto M. Increased mortality and tuberculosis treatment failure rate among Human Immunodeficiency Virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with 'standard' chemotherapy in Kinshasa, Zaire. Am Rev Respir Dis 1991; 144: 750-755.
26. Nunn P, Brindle R, Carpenter L, Odhiambo J, Wasunna K, Newman R. Cohort study of Human Immunodeficiency Virus infection in patients with tuberculosis, Nairobi, Kenya: analysis of early (6 month) mortality. Am Rev Respir Dis 1992; 146: 849-854.
27. Poulsen A G, Aaby P, Gottschau A, Kvinesdaz B B, Dias F, Molbak K. HIV2 infection in Bissau, West Africa, 1987-1989: incidence, prevalences and routes of transmission. J Acquir Immune Defie Syndr 1993; 6: 941-948.
28. Hawken M, Nunn M, Gathua S, Brindle R, Godfrey-Fausset P, Githui W. Increased recurrence of tuberculosis in HIV infected patients in Kenya. Lancet 1993; 342: 332-337.
29. Okwera A, Whalen C, Byekwaso F, Vjecha M, Huebner R, Mugerwa R. Randomised trial of thiacetazone and rifampicin-contaming regimens for pulmonary tuberculosis in HIV-infected Ugandans. Lancet 1994; 344: 1323-1328.
30. Murray C J L, Dejonghe E, Chum H J, Nyangulu D S, Salomao A, Stvblo K. Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries. Lancet 1991; 338: 1305-1308.